Harvard Bioscience Inc (NASDAQ:HBIO)
| 2.96 Delayed Data As of 3:59pm ET |  -0.05 / -1.66%Today’s Change | 1.98 Today|||52-Week Range 6.49 | +6.86% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 28.6M | 33.9M | 28.2M | 29.6M | |
| Cost of Goods Sold | 12.4M | 14.2M | 11.5M | 13.2M | ||
| Depreciation And Amortization | 1.9M | 2.4M | 2.0M | 1.9M | ||
| Operating Expenses | Gross Income | 14.3M | 17.3M | 14.7M | 14.5M | |
| General Expenses | 13.5M | 15.6M | 14.3M | 13.4M | ||
| Other Operating Expenses | -10.0K | 0.00 | 0.00 | 0.00 | ||
| Research And Development | 2.8M | 3.0M | 2.7M | 2.8M | ||
| Total Operating Expenses | 27.7M | 32.1M | 27.8M | 28.4M | ||
| Non-Operating Expenses | Operating Income | 890.0K | 1.7M | 434.0K | 1.2M | |
| Extraordinary Charge | -400.0K | -400.0K | -400.0K | -941.0K | ||
| Interest Expense On Debt | 1.5M | 1.6M | 1.4M | 1.4M | ||
| Other Expenses | 115.0K | -268.0K | -440.0K | 35.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -908.0K | -495.0K | -1.8M | -1.1M | |
| Income Taxes | -652.0K | -3.3M | -576.0K | -885.0K | ||
| Discontinued Operations | 0.00 | -443.0K | 0.00 | 0.00 | ||
| Net Income | -256.0K | 2.3M | -2.4M | -247.0K | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 36.9M | 37.3M | 37.6M | 37.7M | |
| Shares To Calculate EPS Diluted | 36.9M | 37.9M | 37.6M | 37.7M | ||
| Earnings Per Share | EPS | -$0.01 | $0.06 | -$0.06 | -$0.01 | |
| EPS Diluted | -$0.01 | $0.06 | -$0.06 | -$0.01 | ||
